Goldman Sachs’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-50,995
| Closed | -$515K | – | 5421 |
|
|
2022
Q4 | $515K | Hold |
50,995
| – | – | ﹤0.01% | 4070 |
|
|
2022
Q3 | $505K | Sell |
50,995
-5,000
| -9% | -$49.5K | ﹤0.01% | 4232 |
|
|
2022
Q2 | $549K | Hold |
55,995
| – | – | ﹤0.01% | 4318 |
|
|
2022
Q1 | $549K | Hold |
55,995
| – | – | ﹤0.01% | 4509 |
|
|
2021
Q4 | $542K | Hold |
55,995
| – | – | ﹤0.01% | 4462 |
|
|
2021
Q3 | $543K | Buy |
55,995
+1,233
| +2% | +$12K | ﹤0.01% | 4340 |
|
|
2021
Q2 | $530K | Buy |
+54,762
| New | +$530K | ﹤0.01% | 4390 |
|